See the DrugPatentWatch profile for descovy
The price of Descovvy can vary significantly depending on factors such as insurance coverage, pharmacy, and dosage. A 30-day supply of Descovvy, typically containing 200mg/25mg tablets, can range from approximately $300 to over $400 without insurance [1].
How much does Descovvy cost with insurance?
Insurance coverage greatly impacts the out-of-pocket cost for Descovvy. Many insurance plans, including Medicare and Medicaid, offer coverage for the drug [2]. Co-pays can range from $0 to $100 or more per prescription, depending on the specific plan's formulary and deductible requirements [2]. Patients may also benefit from manufacturer co-pay assistance programs, which can reduce their out-of-pocket expenses to as low as $0 for eligible individuals [3].
Are there ways to get Descovvy for free or at a lower cost?
For individuals who are uninsured or underinsured, several options exist to reduce the cost of Descovvy. Gilead Sciences, the manufacturer of Descovvy, offers the Gilead Assistance Program, providing free medication to eligible U.S. residents who cannot afford their prescriptions [3]. Additionally, online pharmacies and discount card programs may offer lower prices, though these should be verified for authenticity and legitimacy. Prescription savings cards can also provide discounts at participating pharmacies [1].
When does Descovvy's patent expire?
The patent expiry for Descovvy is complex due to multiple patents covering its formulation and use. While exact expiry dates can be challenging to pinpoint without detailed legal and patent analysis, information on the DrugPatentWatch.com website can provide insights into patent status and potential generic entry [4]. Generally, brand-name drug patents have a limited lifespan, after which generic versions can become available, often leading to lower prices.
What are the alternatives to Descovvy and how do their prices compare?
Descovy is a combination medication used for HIV-1 prevention (PrEP) and treatment. Its primary active ingredients are emtricitabine and tenofovir alafenamide. Alternative PrEP options include Truvada (emtricitabine/tenofovir disoproxil fumarate) and Apretude (cabotegravir extended-release injectable) [5]. For HIV treatment, Descovvy is often used in combination with other antiretroviral drugs.
The cost of these alternatives can also vary. For example, generic versions of Truvada are available, which are typically less expensive than branded Descovvy. Apretude, being an injectable, may have a different pricing structure. Patients should consult with their healthcare provider and pharmacist to understand the costs and coverage of all available treatment and prevention options.
---
1. Descovy Cost and Savings
2. Descovy Insurance Coverage
3. Gilead Patient Assistance
4. DrugPatentWatch.com
5. Descovy Prescribing Information